APEX-Agents
GPT-5.4 on World125_Task01_NA
Grader rubric
Criteria verdict
States that Impact Therapeutic is a company that primarily sells branded drugs
States the average of COGS as a share of revenue for companies that primarily sell branded drugs is 23%
States that the global COGS as a share of revenue for Impact Therapeutics in 2024 is higher than the average of 23%
States that the US COGS as a share of revenue for Impact Therapeutics in 2024 is higher than the average of 23%
Prompt excerpt
Task context
Using the 2024 annual report, identify whether Impact Therapeutics sells primarily branded drugs. A company sells primarily branded drugs if the majority of drugs have launch dates within the last 7 years. Please use the BCG report to determine the average COGS as a % of revenue for competitors in Impact Therapeutics' segment, based on whether they sell primarily generic drugs, branded, or a mix. Round to the nearest %. In both the global and US geos, state whether Impact Therapeutics is above the segment average calculated from the data in the BCG report. Write your response as a reply to me here.
Response trace
Agent response, tools, files, and edits
On a phone, the interactive viewer works best full-screen — pick the narrative report or the files & trajectory workspace.
Why Eval exists · why Workspace exists
Eval publishes runs. Workspace runs agents on files.
Eval publishes task details, available traces, output files, and rubric results.Workspace is Raycaster’s product for running agents on files.